We are only able to display limited information for this firm. We display more complete information for all of the following firms:

As a result of its recognised IP and litigation expertise, Crowell & Moring is particularly valued by key players from the generics industry. The firm's areas of strength range from advising on marketing authorisations, pricing and reimbursement issues, government reforms, and off-label use questions to representing industry associations in investigations. Recently, there has been markedly increased activity in the digital health space. Co-managing partner Kristof Roox works closely with senior counsel Jurgen Figys on complex mandates.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • 'They have huge knowledge of regulatory matters related to pharmaceuticals. They investigate matters in great detail. They adapt to the client needs and create added value in terms of innovative ideas and thinking out of the box.'
  • 'Kristof Roox is a top partner.'
Abbreviated data is displayed for this firm.

Key clients

  • Sandoz
  • Viatris (formerly Mylan)
Abbreviated data is displayed for this firm.